Nanollose Ltd (ASX: NC6) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Nanollose Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $28.32 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 345.35 million
Earnings per share -0.008
Dividend per share N/A
Year To Date Return 63.27%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Nanollose Ltd (ASX: NC6)
Latest News

miniature rocket breaking out of golden egg representing rocketing share price
Share Market News

Why the Nanollose (ASX:NC6) share price is shooting higher today

The Nanollose Ltd (ASX: NC6) share price is rocketing even higher today following a joint patent application with Grasim Industries…

Read more »

NC6 ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Nanollose Ltd

Nanollose Ltd is a biomaterials company, commercialising technology to create fibres, fabrics, and other materials with minimal environmental impact. Its principal activities include research and development, and promotion of the Company microbial cellulose technologies. The company is engaged in development and commercialization of its Tree-Free rayon fibre for use in textiles (Nullarbor) and non-woven applications (Nufolium).

NC6 Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
22 Apr 2026 $0.08 $0.00 0.00% 436,110 $0.08 $0.08 $0.08
21 Apr 2026 $0.08 $0.00 0.00% 117,509 $0.08 $0.08 $0.08
20 Apr 2026 $0.08 $0.00 0.00% 159,654 $0.08 $0.08 $0.08
17 Apr 2026 $0.08 $0.00 0.00% 267,858 $0.08 $0.08 $0.08
16 Apr 2026 $0.08 $0.00 0.00% 335,636 $0.08 $0.08 $0.08
15 Apr 2026 $0.08 $0.00 0.00% 137,318 $0.08 $0.08 $0.08
14 Apr 2026 $0.08 $0.00 0.00% 421,456 $0.08 $0.08 $0.08
13 Apr 2026 $0.08 $0.00 0.00% 332,085 $0.08 $0.08 $0.08
10 Apr 2026 $0.08 $0.00 0.00% 660,588 $0.08 $0.08 $0.08
09 Apr 2026 $0.08 $0.00 0.00% 589,271 $0.08 $0.08 $0.07
08 Apr 2026 $0.08 $0.00 0.00% 458,743 $0.07 $0.08 $0.07
07 Apr 2026 $0.07 $0.00 0.00% 206,763 $0.07 $0.07 $0.07
02 Apr 2026 $0.07 $0.00 0.00% 182,000 $0.07 $0.07 $0.07
01 Apr 2026 $0.07 $0.00 0.00% 339,800 $0.07 $0.07 $0.07
31 Mar 2026 $0.07 $0.00 0.00% 10,000 $0.07 $0.07 $0.07
30 Mar 2026 $0.07 $0.01 15.87% 588,006 $0.06 $0.07 $0.06
27 Mar 2026 $0.06 $-0.01 -14.29% 100,648 $0.07 $0.07 $0.06
26 Mar 2026 $0.07 $0.00 0.00% 324,531 $0.07 $0.07 $0.07
25 Mar 2026 $0.07 $0.00 0.00% 582,622 $0.07 $0.07 $0.06
24 Mar 2026 $0.07 $0.00 0.00% 56,486 $0.07 $0.07 $0.07

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
03 Dec 2025 Heidi Beatty Issued 1,000,000 $40,000
Issue of options.
01 Aug 2025 Andrew Moullin Buy 100,000 $8,300
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Winton William Willesee Non-Executive Director Sep 2014
Mr Willesee is an experienced company director with over 20 years' experience in multiple roles within the Australian capital markets. He has experience with ASX listed and other companies over a range of industries having been involved with ventures from early stage through to capital development projects. He has a core expertise in strategy, company development, corporate governance, company public listings, merger and acquisition transactions and corporate finance.
Dr Wayne Morris Best Executive ChairmanExecutive Director Sep 2014
Dr Best has 40 years' experience in organic chemistry both in academia, government and industry. He spent ten years at the Chemistry Centre (WA) where he was responsible for the formation and running of the Medicinal & Biological Chemistry Section which undertook collaborative R&D into drug discovery and contract synthesis for the drug discovery and pharmaceutical industries. He then founded Epichem Pty Ltd.
Mr Andrew Moullin Non-Executive Director Jul 2025
Mr Moullin is an experienced executive with over two decades in legal, commercial, and corporate leadership roles. He brings expertise in strategic project execution, complex commercial negotiations, and robust corporate governance. Andrew has held senior roles at Iluka Resources Limited, DLA Piper, Macro Metals Limited, Fivemark Partners and CLSA, as well as founding and managing a range of other businesses. His expertise encompasses M&A, project planning and execution, capital raisings, and investor relations initiatives.
Mrs Erlyn Dawson Company Secretary
-
Erlyn Dawson Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Netwealth Investments Limited <Wrap Services A/C> 25,061,048 8.21%
Conbrio Beteiligungen AG 20,625,000 6.75%
Wayne Morris Best <Wayne & Debra Best Fam A/C> 20,225,002 6.62%
Gleneagle Securities Nominees Pty Limited 14,375,000 4.71%
Chincherinchee Nominees Pty Ltd 12,500,000 4.09%
Azalea Family Holdings Pty Ltd <No 2 A/C> 12,358,006 4.05%
Spinite Pty Ltd 9,580,000 3.14%
Diamond Construct Pty Ltd 7,500,000 2.46%
Invia Custodian Pty Limited <The Fry Family A/C> 6,572,909 2.15%
Mr Jason Duncan Maclaurin 6,351,190 2.08%
Citicorp Nominees Pty Limited 5,992,302 1.96%
Mr John Moursounidis <Moursounidis Family A/C> 5,934,523 1.94%
The Key Company Pty Ltd 5,166,667 1.69%
Mr Jason Stephen Tincey & Mrs Holly Elise Tincey <Stellas Treasure A/C> 4,013,131 1.31%
Challen 7 Pty Ltd <Pashro Unit A/C> 3,994,287 1.31%
Madeiros Pty Ltd <Visser Super Fund A/C> 3,805,015 1.25%
Mr Andreas Steinwachs 3,666,667 1.20%
Mr Dean Anthony Mackenzie 3,481,540 1.14%
Dutch Ink (2010) Pty Ltd 3,047,875 1.00%
Tripit Pty Ltd <Peter Heather Wells S/F A/C> 3,000,000 0.98%

Profile

since

Note